Annual report for Lincoln Pharmaceuticals Ltd. for FY-2012
15-05-2012
Limited Review for Dec 31, 2011
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2011.23-02-2012
Financial Results for Dec 31, 2011
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.14-02-2012
Press Release
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 11, 2012 regarding an agreement with Phafag AG, Switzerland.Press Release:"Lincoln Pharmaceuticals Ltd (LPL), a world class pharmaceutical Company had entered into an agreement with Phafag AG, Switzerland, for its Carovenne molecule for the treatment of Tinnitus - commonly known as "ringing in the ear" a condition where the inner hair cells get damaged...12-01-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:23-12-2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mansi Munjal Patel has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE.23-12-2011
Investment in Lincoln Parenteral Ltd
Lincoln Pharmaceuticals Ltd has informed BSE that the Company has acquired / purchased 62 Lacs equity shares of M/s. Lincoln Parenteral Ltd and by virtue of said acquisition / purchase of equity share, M/s. Lincoln Parenteral Ltd has become subsidiary Company w.e.f. December 06, 2011.07-12-2011
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:05-12-2011
Financial Results for Sep 30, 2011
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Period ended September 30, 2011.12-11-2011
Outcome of AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have passed the following resolution:1. Adoption of the Audited Balance Sheet as at March 31, 2011 and Profit and Loss Account for the year ended on that date and Report of the Director and Auditors thereon....30-09-2011